Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin (2025)
- Authors:
- Autor USP: LOURENÇO, FELIPE REBELLO - FCF
- Unidade: FCF
- DOI: 10.1016/j.jpba.2025.116994
- Subjects: INDÚSTRIA FARMACÊUTICA; COMPRIMIDOS; MEDIÇÃO DE RISCO; MÉTODO DE MONTE CARLO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Pharmaceutical and Biomedical Analysis
- ISSN: 0731-7085
- Volume/Número/Paginação/Ano: v. 265, p. 1-11 art. 116994, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SANTOS, Monique Silva dos et al. Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin. Journal of Pharmaceutical and Biomedical Analysis, v. 265, p. 1-11 art. 116994, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2025.116994. Acesso em: 16 fev. 2026. -
APA
Santos, M. S. dos, Nascimento, D. D. do, Medeiros, J. J. S., Lourenço, F. R., Oliveira, C. A. de, & Prado, L. D. (2025). Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin. Journal of Pharmaceutical and Biomedical Analysis, 265, 1-11 art. 116994. doi:10.1016/j.jpba.2025.116994 -
NLM
Santos MS dos, Nascimento DD do, Medeiros JJS, Lourenço FR, Oliveira CA de, Prado LD. Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2025 ; 265 1-11 art. 116994.[citado 2026 fev. 16 ] Available from: https://dx.doi.org/10.1016/j.jpba.2025.116994 -
Vancouver
Santos MS dos, Nascimento DD do, Medeiros JJS, Lourenço FR, Oliveira CA de, Prado LD. Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2025 ; 265 1-11 art. 116994.[citado 2026 fev. 16 ] Available from: https://dx.doi.org/10.1016/j.jpba.2025.116994 - Setting multivariate and correlated acceptance limits for assessing the conformity of items
- Doseamento microbiológico de gentamicina por difusão em agar-proposta de delineamento experimental
- Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures
- Application of measurement uncertainty on conformity assessment in pharmaceutical drug products
- Top-down evaluation of the matrix effects in microbial enumeration test uncertainty
- Development and optimization of a stability-indicating chromatographic method for verapamil hydrochloride and its impurities in tablets using an analytical quality by design (AQbD) approach
- Reduced incubation time for inhibition zone formation based on diffusion and growth mechanism elucidation
- Measurement uncertainty in pharmaceutical analysis and its application
- In vitro therapeutic equivalence of ciprofloxacin ophthalmic drugs based on measurement uncertainty and Monte Carlo simulations
- Physicochemical characterization of a lycopene-loaded mesoporous silica nanoparticle formulation
Informações sobre o DOI: 10.1016/j.jpba.2025.116994 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
